Ajay goel
Ajay goel
Beckman Research Institute, City of Hope Comprehensive Cancer Center, Duarte, CA
Verified email at - Homepage
Cited by
Cited by
Curcumin as “Curecumin”: from kitchen to clinic
A Goel, AB Kunnumakkara, BB Aggarwal
Biochemical pharmacology 75 (4), 787-809, 2008
Microsatellite instability in colorectal cancer
CR Boland, A Goel
Gastroenterology 138 (6), 2073-2087. e3, 2010
Fusobacterium nucleatum increases proliferation of colorectal cancer cells and tumor development in mice by activating toll-like receptor 4 signaling to nuclear factor− κB, and …
Y Yang, W Weng, J Peng, L Hong, L Yang, Y Toiyama, R Gao, M Liu, ...
Gastroenterology 152 (4), 851-866. e24, 2017
Epigenetic alterations in colorectal cancer: emerging biomarkers
Y Okugawa, WM Grady, A Goel
Gastroenterology 149 (5), 1204-1225. e12, 2015
A randomized, pilot study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis
B Chandran, A Goel
Phytotherapy research 26 (11), 1719-1725, 2012
Curcumin, the golden spice from Indian saffron, is a chemosensitizer and radiosensitizer for tumors and chemoprotector and radioprotector for normal organs
A Goel, BB Aggarwal
Nutrition and cancer 62 (7), 919-930, 2010
MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis
K Hur, Y Toiyama, M Takahashi, F Balaguer, T Nagasaka, J Koike, ...
Gut 62 (9), 1315-1326, 2013
Molecular classification and correlates in colorectal cancer
S Ogino, A Goel
The Journal of Molecular Diagnostics 10 (1), 13-27, 2008
Cancer chemoprevention by dietary polyphenols: promising role for epigenetics
A Link, F Balaguer, A Goel
Biochemical pharmacology 80 (12), 1771-1792, 2010
Serum miR-21 as a diagnostic and prognostic biomarker in colorectal cancer
Y Toiyama, M Takahashi, K Hur, T Nagasaka, K Tanaka, Y Inoue, ...
Journal of the national cancer institute 105 (12), 849-859, 2013
Use of 5-fluorouracil and survival in patients with microsatellite-unstable colorectal cancer
JM Carethers, EJ Smith, CA Behling, L Nguyen, A Tajima, RT Doctolero, ...
Gastroenterology 126 (2), 394-401, 2004
Specific inhibition of cyclooxygenase-2 (COX-2) expression by dietary curcumin in HT-29 human colon cancer cells
A Goel, CR Boland, DP Chauhan
Cancer letters 172 (2), 111-118, 2001
Protective effects of zinc on lipid peroxidation, antioxidant enzymes and hepatic histoarchitecture in chlorpyrifos-induced toxicity
A Goel, V Dani, DK Dhawan
Chemico-biological interactions 156 (2-3), 131-140, 2005
Epigenetics of colorectal cancer: biomarker and therapeutic potential
G Jung, E Hernández-Illán, L Moreira, F Balaguer, A Goel
Nature reviews Gastroenterology & hepatology 17 (2), 111-130, 2020
BRCA1 expression modulates chemosensitivity of BRCA1-defective HCC1937 human breast cancer cells
P Tassone, P Tagliaferri, A Perricelli, S Blotta, B Quaresima, ML Martelli, ...
British journal of cancer 88 (8), 1285-1291, 2003
Fecal MicroRNAs as novel biomarkers for colon cancer screening
A Link, F Balaguer, Y Shen, T Nagasaka, JJ Lozano, CR Boland, A Goel
Cancer epidemiology, biomarkers & prevention 19 (7), 1766-1774, 2010
Frequent inactivation of PTEN by promoter hypermethylation in microsatellite instability-high sporadic colorectal cancers
A Goel, CN Arnold, D Niedzwiecki, JM Carethers, JM Dowell, ...
Cancer research 64 (9), 3014-3021, 2004
Circular RNA ciRS-7—a promising prognostic biomarker and a potential therapeutic target in colorectal cancer
W Weng, Q Wei, S Toden, K Yoshida, T Nagasaka, T Fujiwara, S Cai, ...
Clinical Cancer Research 23 (14), 3918-3928, 2017
Role of hMLH1 promoter hypermethylation in drug resistance to 5‐fluorouracil in colorectal cancer cell lines
CN Arnold, A Goel, CR Boland
International journal of cancer 106 (1), 66-73, 2003
Characterization of sporadic colon cancer by patterns of genomic instability
A Goel, CN Arnold, D Niedzwiecki, DK Chang, L Ricciardiello, ...
Cancer research 63 (7), 1608-1614, 2003
The system can't perform the operation now. Try again later.
Articles 1–20